Individuals with long COVID experiencing challenges in resuming or sustaining employment. Infections and Infestations
Conditions
Interventions
This study is a multicenter, non-randomised, single-arm intervention development study using the person-based approach, comprising interviews and clinical contact, informed by workshops and findings f
and followed by participant qualitative assessment/acceptability interviews.
Participants consenting to take part will receive vocational rehabilitation delivered by an Occupational Therapist (OT) e
Sponsors
University of Nottingham
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Working age (18-65) 2. Tested positive for COVID-19 3. Employed, self-employed, in full-time education or voluntary work 4. Able to give informed consent 5. Assessed as Level 1-6 (requires modifications) on the Work Ability Support Scale (WSS) and/or or self-identified need for support with returning to or remaining in work or self-reported ‘work issues’ (contextual/workplace factors affecting job stability). This will be completed by a trained occupational therapist providing rehabilitation in the vocational rehabilitation outpatient service. For participants from the Royal Free, the WSS will be conducted post-consent.
Exclusion criteria
Exclusion criteria: 1. Active mental or physical condition causing physical deconditioning 2. Current diagnosis of other respiratory illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The extent to which the participant's individual goals are achieved measured using the Goal Attainment Scale (GAS) following the intervention 2. Whether or not reliable change occurred measured using the Leeds Reliable Change index calculator at one timepoint | — |
Secondary
| Measure | Time frame |
|---|---|
| The following secondary outcome measures are assessed at baseline, 6, 12 and 16 weeks unless otherwise stated: 1. Acceptability if the intervention will be measured using qualitative interviews after completion of the intervention 2. Depression will be measured using the Patient Health Questionnaire (PHQ-9) 3. Anxiety will be measured using Generalised Anxiety Disorder Assessment (GAD-7) 4. Trauma will be measured using the Trauma Screening Questionnaire (TSQ) 5. Fear of COVID-19 will be measured using the Fear of COVID-19 scale 6. Exposure to stigma regarding COVID-19 infection will be measured using the COVID-19 Stigma Scale 7. Cognitive and emotional presentation of illness will be measured using the Brief Illness Perception Questionnaire (BIPQ) 8. Disability and function impairment will be measured using the World Health Organisation Disability Assessment Schedule (WHODAS-ii) 9. Breathlessness levels will be measured using the MRC Breathlessness Scale 10. Fatigues will be measured using the Chalder fatigue Scale 11. Impairment in functioning will be measured using the Work and Social Adjustment Scale (WSAS) 12. The participants' self-efficacy to return to work will be measured using the Return to Work Efficacy Scale 13. The financial impact of work difficulties will be measured by asking about access to benefits, loss in earnings since COVID, sick days taken (and whether they were paid) and concerns about financial implications in general 14. Impairment at work will be measured using the Work Productivity and Activity Impairment Questionnaire: General Health V2.0 | — |
Countries
England, United Kingdom
Contacts
Public Contactclem Boutry
Outcome results
None listed